Resveratrol Hydrogel Shields Heart Cells from Oxidative Damage After Heart Attack

Myocardial infarction remains one of the leading causes of death worldwide, and a major obstacle to cardiac regenerative medicine is the hostile oxidative stress environment at injury sites, which destroys transplanted therapeutic cells before they can take effect.

To address this, researchers from Hainan Medical University and Harbin Medical University engineered a thermo-sensitive injectable hydrogel called RM-CH, composed of chitosan loaded with resveratrol micelles (RES-M). Resveratrol is a naturally occurring polyphenol with well-documented antioxidant and cardioprotective properties, but its poor bioavailability has historically limited clinical utility. Encapsulating it in micelles within a hydrogel scaffold aims to overcome this barrier.

The RM-CH hydrogel demonstrated stronger scavenging activity against DPPH and ABTS free radicals than ascorbic acid, the current industry standard antioxidant reference compound. It also showed good biodegradability, histocompatibility, and cytocompatibility, meaning it integrates safely with biological tissue. Critically, the injection process itself did not induce cell damage — an important practical requirement for clinical translation.

Using DHE and DCFH-DA fluorescent staining techniques, the team confirmed that RM-CH reduced reactive oxygen species levels and improved cardiomyocyte survival in oxidative stress conditions. Live/Dead staining of cells embedded within the hydrogel further validated that resveratrol micelles were the active rescue component.

These findings suggest RM-CH could serve as an effective scaffold for injectable cardiac tissue engineering, enabling cell delivery to infarct sites while simultaneously neutralizing the damaging oxidative microenvironment. However, the study is preclinical and limited to cell-based assays, so in vivo cardiac efficacy and long-term safety remain to be established.